How Barbara Imperiali Maps the Secret Language of Sugar in Cells
In the bustling labs of MIT, a scientist peers into the molecular conversations that govern life itself. Barbara Imperiali—equally at home in chemistry and biology departments—deciphers a cryptic biochemical dialect where sugars "talk" to proteins, dictating their behavior in health and disease. Her pioneering work illuminates glycoconjugates, complex sugar-protein hybrids essential to infections, immunity, and cellular communication 1 7 .
Once dismissed as mere decoration, these molecules are now known to orchestrate biological events with precision. Imperiali's genius lies in building chemical tools to eavesdrop on these conversations, revealing targets for next-generation antibiotics and diagnostics 2 .
Glycobiology research at the chemistry-biology interface
Born to a WWII Italian submarine captain and British WREN officer
Studied medicinal chemistry at University College London
MIT, synthetic organic chemistry under Satoru Masamune
Brandeis University with enzymologist Robert Abeles
Caltech (1989-1999), MIT (1999-present)
Barbara Imperiali's path began far from the lab bench. Born to a World War II Italian submarine captain and a British WREN officer, she was the first in her family to pursue science . At University College London, medicinal chemistry captivated her with its fusion of molecular design and biological impact. Drawn to MIT for her PhD, she mastered synthetic organic chemistry under Satoru Masamune, constructing intricate antibiotics called ansamycins 3 8 .
"I've always thought like a chemist. The molecules are in my head. But biology gives me the problems to solve."
But a pivotal shift occurred during postdoctoral work with enzymologist Robert Abeles at Brandeis. There, she designed peptide-based protease inhibitors, igniting her passion for chemical biology—a field then in its infancy 3 4 .
Her career defied categorization. At Caltech (1989–1999), she collaborated with pioneers like Dennis Dougherty, applying chemistry to neurobiology. Returning to MIT in 1999, she navigated dual roles: chemists saw her as a biologist; biologists called her their "go-to chemist" 4 8 . This duality proved strategic. As glycobiology emerged, her hybrid skills positioned her to crack its toughest puzzles.
Glycosylation—the attachment of sugars to proteins—is a universal language of life. From bacteria to humans, it directs protein folding, immune responses, and infection. Pathogens like Campylobacter and Salmonella use glycans to camouflage themselves or invade host cells 1 7 . Imperiali's key insight was that understanding this process required dissecting membrane-embedded assembly lines where sugars are activated, transferred, and attached.
Imperiali zeroed in on PGTs—enzymes that launch glycosylation by anchoring the first sugar to a lipid carrier. For decades, their mechanisms were opaque. In a landmark study, her team reconstructed a PGT's activity using nanodisc technology—synthetic membrane bubbles that mimic cellular environments 1 .
Technology | Function | Impact |
---|---|---|
Lipid Bilayer Nanodiscs | Provides native-like membrane environments for studying PGT enzymes | Enabled first functional reconstitution of PGTs 1 |
Single-Molecule FRET | Tracks real-time conformational changes in proteins | Revealed dynamic "ping-pong" mechanism of PGTs 1 |
Uridine Bisphosphonates | Synthetic molecules that selectively inhibit PGT superfamilies | Identified new antibiotic targets 1 |
How does a PGT enzyme couple sugar activation with transfer across membranes? Hypotheses predicted a "ping-pong" mechanism, but direct evidence was elusive.
The FRET data captured the PGT "in motion":
Enzyme State | FRET Efficiency | Domain Separation |
---|---|---|
Sugar-Free (Resting) | Low | 6.0 nm |
Sugar-Bound (Active) | High | 4.5 nm |
Post-Transfer (Reset) | Low | 6.0 nm |
Single-molecule FRET instrumentation used in Imperiali's research
This "ping-pong" motion confirmed a covalent enzyme intermediate—resolving decades of debate. The study also showed PGTs function as monotopic enzymes, partially embedded in membranes but not spanning them 1 7 .
"Don't chase moving targets. Find what excites you, even when data refuses to cooperate."
Barbara Imperiali's journey—from ansamycin synthesis to bacterial glycan warfare—exemplifies how chemical creativity unlocks biological mysteries. Her fluorescent spies and membrane mimics have rewritten glycobiology textbooks, revealing enzymes that dance as they work. As antibiotic resistance escalates, her tools offer hope: by targeting PGTs, we might disarm deadly pathogens. For Imperiali, the next frontier is clear—"Apply chemistry to dissect complexity, then share those tools to light up science for others" 4 .